Blood Collection Market Is Projected To Witness Growth Based On The Increasing Incidence Of Infectious & Non-Communicable Diseases Till 2025:Grand View Research,inc.
The global blood
collection market is expected to reach a value of USD 13.3 billion
by 2025, according to a new report by Grand View Research, Inc. The increasing
incidence of infectious and non-communicable diseases is a major factor
anticipated to propel the market growth during the forecast period. According
to the Centers for Disease Control and Prevention (CDC), in 2013, around 19.3
million people visited the physician’s clinic for infectious and parasitic
diseases testing in the U.S. Moreover, according to International Diabetes
Federation, 415 million people suffered from diabetes in 2014 and this number
is expected to rise up to 642 million by 2040. Thus, the increasing incidence
of accidents and trauma cases is another factor that drives the demand for
blood collection products for therapeutic application.
The increasing number of surgical
procedures is an additional key factor contributing to the growth. The
escalating number of accidental injury cases is expected to propel the demand
for target market products for therapeutics application. According to the CDC,
in the U.S, around 31.0 million patients visited emergency centers for
unintentional injuries in 2014. Thus, the demand for blood collection products
such as bags, needles, and syringes is growing at a high rate, which is
expected to boost the growth during the forecast period.
The U.S. blood collection market, by end-use, 2014-2025
(USD Million)
Browse full research report on Blood
Collection Market
Further key findings from the report suggest:
- The needles
and syringes segment was the largest grossing segment of the blood
collection market in 2015 owing to the growing application of these
devices in diagnosis and treatment of various disorders like diabetes and
blood-related diseases
- The
diagnostics application segment held the largest revenue share in 2015,
owing to rising geriatric population and escalating prevalence of
infectious & non-communicable diseases
- In 2015, the
hospitals segment accounted for the largest share in the market due to an
upsurge in the incidence of trauma & accidental cases along with
growing number of surgical procedures
- North America
held the largest share of the blood collection market in the year 2015.
This region is estimated to uphold its dominance during the study period
- The presence
of a highly developed healthcare infrastructure and advanced blood
collection products is anticipated to boost the growth in North America
during the forecast period
- Some of the
key companies include Abbott Laboratories, NIPRO Medical Corp., Becton,
Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL
s.r.l.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment